Universitat de Girona posted this:Web-CDSS HTE 3.0 familiar hypercolesterolimiaThe present technology is a Web application integrable in a public or private health system, which facilitates the detection of dyslipidemia in general, and familiar hypercholesterolemia in particular. WEB-CDSS HTE 3.0 allows to customize the hypolipidemic treatment, considering its cardiovascular risk, concomitant diseases and drugs.It is based on the European Dyslipemia Guidelines of 2016
Universidad de Alcalá-OTRI posted this:Carbosilane dendrimers and their use as antiviralsThe research group in "Dendrimers for Biomedical Applications" of the University of Alcalá presents these highly branched macromolecules synthesized from a polyfunctional nucleus, of carbosilane structure and functionalized in its periphery with anionic groups that give the macromolecule a negative net charge. In addition, the invention relates to the use of the dendrimers as an antimicrobial and the process for obtaining them. The group seeks to reach collaboration agreements, licensing or commercial agreements with technical assistance, with companies in the biotechnology, pharmaceutical and biomedicine sectors in general.
Merck KGaA posted this:Technology for Lysophosphatidic Acid (LPA) Receptor antagonistsMerck has developed and patented the results of its intense R&D activities for the identification of small organic molecules as antagonists to certain LPA receptors (LPAR1, -R2, -R3). Herein described are LPA-R2 receptor selective inhibitors. Based upon a rational screening cascade established, compounds have been identified and characterized with regard to their specific in vitro and cellular activities. The package includes access to the IP, experimental results, and materials. Merck offers the unique chance to acquire this promising program.
Merck KGaA posted this:Technology for Serum and Glucocorticoid regulated kinase (SGK) inhibitorsMerck KGaA, Darmstadt, Germany, has developed and patented the results of its intense R&D activities for the identification of small organic molecules as SGK1 inhibitors. Based upon a rational screening cascade established, compounds have been identified and characterized with regard to their specific in vitro, cellular and in vivo activities. The package includes access to the IP, experimental results, and materials. Merck KGaA, Darmstadt, Germany, offers the unique chance to acquire this promising program.
Small and Medium Enterprise
Creative Animodel posted this:CAR-T Preclinical in vivo StudyCreative Animodel provides customized preclinical testing services for your CAR-T cells. In cooperation with our CAR-T cells production division, Creative Biolabs, we are able to provide you with one-stop full service of both CAR-T production and preclinical testing. We also offer services for customized CAR-T cell toxicity management assessments.
CD Genomics posted this:DNA & Genomics Sequencing ServiceCD Genomics proprietary GenSeqTM Technology provides advanced multi-omics and bioinformatics service solutions for its global The Specialties of GenSeqTM customers who do research in laboratory. Equipped with the broadest industrial array of cutting-edge technologies and coupled with a group of experienced scientists and bioinformaticians, CD Genomics possesses significant contributions to genetic research.
Fundació URV posted this:Improving the efficacy of autologous stem cell transplantation from adipose tissue in patients with Crohn's diseaseThe invention relates to a method for obtaining stem cells with immunomodulatory properties derived from adipose tissue. The invention presents relevant applications in order to cure or improve Crohn's disease (EC) and the resulting complications such as perianal fistulas using cellular therapy.
Alfonso del Rey Pérez posted this:
Licensing Manager at Institut Català de Nanociència i Nanotecnologia
Fundació URV posted this:Predictive pharmacokinetics/ pharmacodynamic (system biology) evaluation of drug and other compound’s efficacy and safetyPharmacokinetics/ pharmacodynamic (system biology) PBPK/PD model is a powerful mechanistic tool used for designing of trials in different phases, prospective and retrospective analysis for bridging gaps in an experiment, target validation, safety and efficacy analysis and early identification of risk associated with specific group of population.
Cracow University of Technology posted this:The new lupeol derivative and the method of obtaining.This invention relates to a biologically active compound, the derivative of natural triterpene lupeol. This derivative is active for human skin cells, improving their proliferation process. In addition, the substance has the ability to neutralize free radicals. The described derivative can be used as an active ingredient in pharmaceutical and cosmetic preparations dedicated for damaged or burned skin, as well as in anti-aging cosmetics.
Universidad de Alcalá-OTRI posted this:Carbosilane dendrimers with polyphenolic groups. Uses as antioxidants and anticancer.The "Dendrimer for biomedical applications Research Group" at Alcalá University presents dendritic macromolecules with skeleton of carbosilane nature that contain in their structure polyphenolic groups (GPF). These compounds are powerful antioxidants and free radical scavengers, as well as anticancer agents, with application in sectors such as food, cosmetics and pharmaceutical industry. The invention provides a process for its procurance and uses.
Universitat de Lleida posted this:New method to increase yolk color and egg nutritional qualityThe University of Lleida seeks industrial partners with expertise in the sector of crop production to adopt a new technology of optimized feed solution for egg producers (poultry market). The type of partner sought is for the regulatory codevelopment and commercialization of our solution under a technology license agreement.
Universitat de Lleida posted this:Method based on a nutritional intervention to fight coccidiosisWe seek industrial partners with expertise in the sector of crop production to adopt a new technology useful to deliver optimized feed solution to fight coccidiosis. The type of partner sought is mainly for the regulatory codevelopment and the commercialization of our solution under a technology license agreement. The technology developed relates to a novel genetically engineered variety of maize accumulating extraordinary levels of carotenoids (β-carotene, lycopene, zeaxanthin and lutein). Poultry raised on this corn were healthy and exhibited substantially higher levels of resistance to coccidiosis, less foot pad dermatitis, reduced number of ulcers and less excretion of pathogen oocysts in feces. Carotenoids accumulate in several tissues (skin, dermis, muscles and fat), conferring high nutritional value and greater consumer acceptance.
Technology Transfer Office
TTPU posted this:Anti-adhesive Biopolymer CoatingResearchers have developed an anti-adhesive coating based on a polymer naturally and sustainable produced by a marine bacterium. This coating prevents the bacterial adhesion and the subsequent biofilm formation that usually leads to host bacterial infections difficult to eradicate and control with the antibiotics currently in use, namely in hospital environments. This coating can be applied in a cost effective way to a broad range of materials through the application of a universal glue.
University of Huelva posted this:New plasmid and strategy for expression of exogenous proteins in eukaryotic microalgae by translational fusion with a selectable markerThis plasmid solves the problems of low efficiency and instability of transgenes in the genetic manipulation of microalgae, as well as offers a procedure for the expression of high amounts of the protein of interest and better transformation efficiency